FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 60 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,093,395 | -28.7% | 1,018,679 | +0.4% | 0.00% | – |
| Q2 2023 | $7,145,157 | +12.8% | 1,014,937 | -0.7% | 0.00% | – |
| Q1 2023 | $6,336,183 | -2.4% | 1,021,965 | +0.4% | 0.00% | – |
| Q4 2022 | $6,494,126 | -25.3% | 1,017,888 | +0.5% | 0.00% | – |
| Q3 2022 | $8,691,000 | -36.6% | 1,012,922 | +0.5% | 0.00% | – |
| Q2 2022 | $13,703,000 | +4.5% | 1,007,589 | +17.1% | 0.00% | – |
| Q1 2022 | $13,109,000 | -32.1% | 860,770 | +1.9% | 0.00% | – |
| Q4 2021 | $19,318,000 | +65.1% | 844,691 | +0.6% | 0.00% | – |
| Q3 2021 | $11,699,000 | +60.3% | 839,917 | +22.8% | 0.00% | – |
| Q2 2021 | $7,296,000 | +35.9% | 683,778 | +67.9% | 0.00% | – |
| Q1 2021 | $5,369,000 | -34.3% | 407,334 | +1.0% | 0.00% | – |
| Q4 2020 | $8,178,000 | – | 403,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,674,120 | $63,370,600 | 4.60% |
| Euclidean Capital LLC | 3,147,522 | $15,737,610 | 1.72% |
| Birchview Capital, LP | 264,843 | $1,324,215 | 1.13% |
| Artal Group S.A. | 1,720,720 | $8,604 | 0.37% |
| Rockwood Wealth Management, LLC | 214,677 | $1,073,385 | 0.18% |
| Alphabet Inc. | 500,901 | $2,504,505 | 0.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $3,887,625 | 0.09% |
| CORNERCAP INVESTMENT COUNSEL INC | 25,819 | $129,095 | 0.02% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 343,720 | $1,718,600 | 0.02% |
| WADE G W & INC | 107,770 | $539 | 0.02% |